Business
FAE: Strong revenue and profit growth driven by Pharma, with robust outlook for year-end
FAE: Strong revenue and profit growth driven by Pharma, with robust outlook for year-end
About this update from Faes Farma, S.a.
Revenue and profit grew strongly in the first nine months of 2024, led by Pharma in Spain and international markets. Guidance for year-end is at the high end of forecasts, with continued investment in R&D and new plant operations.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.